Results 11 to 20 of about 588,781 (167)

In vitro and in vivo postmarketing surveillance of valsartan, alone or in combination with amlodipine or hydrochlorthiazide, among Palestinian hypertensive patients

open access: yesTherapeutics and Clinical Risk Management, 2016
Abdel Naser Zaid,1 Masshour Ghanem,2 Dua’a Shweiki,1 Hala Shtewi,1 Raja’ Shaheen,1 Sondos Al Helaly,1 Zeina Khayyat,1 Rowa’a Al Ramahi,1 Sa’ed H Zyoud1 1Department of Pharmacy, Faculty of Medicine & Health Sciences, An-Najah ...
Zaid AN   +8 more
doaj   +1 more source

Enhancing Postmarketing Surveillance Systems for Improved Pharmacovigilance [PDF]

open access: yes, 2023
Postmarketing surveillance systems play a critical role in monitoring the safety and effectiveness of drugs in real-world settings. However, there is a growing need to enhance these systems to ensure early detection and effective management of adverse ...
Muhammad Aoun, Suresh Budha Dahal
core   +1 more source

Post-marketing stability surveillance: Amoxicillin

open access: yesSouth African Family Practice, 2006
Background: To ensure the successful treatment of infectious disease using antimicrobial therapy, a sufficient concentration of the stable, active drug is required at the site of infection.
K.K. Naidoo   +5 more
doaj   +1 more source

Safety and effectiveness of adalimumab in the treatment of ulcerative colitis: results from a large-scale, prospective, multicenter, observational study [PDF]

open access: yesIntestinal Research, 2021
Background/Aims Adalimumab has been shown to induce and maintain clinical remission in patients with moderate to severe ulcerative colitis (UC). However, no large-scale population-based studies have been performed in Japan.
Haruhiko Ogata   +4 more
doaj   +1 more source

Postmarket surveillance: a review on key aspects and measures on the effective functioning in the context of the United Kingdom and Canada

open access: yesTherapeutic Advances in Drug Safety, 2019
Regulatory approvals for the marketing of medicinal products authorize medical practitioners to prescribe drugs to a group of patients that are defined within the license of the medicinal product.
Nikhil Raj   +5 more
doaj   +1 more source

Uncovering Knowledge Gaps in the Safety Profile of Antiangiogenic Drugs in Cancer Patients: Insights from Spontaneous Reporting Systems Studies

open access: yesPharmaceuticals, 2023
Global repositories of postmarketing safety reports improve understanding of real-life drug toxicities, often not observed in clinical trials. The aim of this scoping review was to map the evidence from spontaneous reporting systems studies (SRSs) of ...
Valerio Ciccone   +3 more
doaj   +1 more source

Hallucinatory Side Effects of ADHD Drugs

open access: yesPediatric Neurology Briefs, 2009
Clinical trial and postmarketing surveillance data for drugs used in treatment of attention deficit hyperactivity disorder were analyzed to determine the frequency of hallucinations and other psychotic side effects, in a study at the US Food and Drug ...
J Gordon Millichap
doaj   +1 more source

Post-marketing safety surveillance of the rotavirus vaccine in India

open access: yesVaccine: X, 2023
Background: ROTASIIL, an oral live attenuated bovine-human reassortant pentavalent rotavirus vaccine, was approved in 2017. This post-marketing surveillance (PMS) was conducted to collect real-world data on the safety of ROTASIIL in India.
Gagandeep Kang   +9 more
doaj   +1 more source

Analyzing the U.S. Post-marketing safety surveillance of COVID-19 vaccines

open access: yesSaudi Pharmaceutical Journal, 2022
Introduction: Since December 2020, three COVID-19 vaccines have been authorized in the United States (U.S.) and were proceeded by large immunization programs. The aim of this study was to characterize the U.S.
Omar M. Albalawi   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy